» Articles » PMID: 31106235

Murine Pharmacokinetic Studies

Overview
Journal Bio Protoc
Specialty Biology
Date 2019 May 21
PMID 31106235
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Murine pharmacokinetics (PK) represents the absorption, distribution, metabolism, and elimination of drugs from the body, which helps to guide clinical studies, ultimately resulting in more effective drug treatment. The purpose of this protocol is to describe a serial bleeding protocol, obtaining blood samples at six time points from single mouse to yield a complete PK profile. This protocol has proved to be rapid, highly repeatable, and relatively easy to acquire. Comparing with the conventional PK studies, this method not only dramatically reduces animal usage, but also decreases sample variation obtained from different animals.

Citing Articles

Based on UPLC-Q-TOF/MS and Network Pharmacology to Explore the Mechanism of Qingre Lishi Decoction in the Treatment of Psoriasis.

Wei J, Liu Z, Li M, Du L, Zhu X, Leng Y Drug Des Devel Ther. 2024; 18:3871-3889.

PMID: 39219696 PMC: 11366256. DOI: 10.2147/DDDT.S467066.


Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen.

Drabison T, Boeckman M, Yang Y, Huang K, de Bruijn P, Nepal M Cancer Res Commun. 2024; 4(9):2489-2497.

PMID: 39207193 PMC: 11417675. DOI: 10.1158/2767-9764.CRC-24-0332.


Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive UHPLC-MS/MS method for murine plasma analysis.

Anabtawi N, Drabison T, Jin Y, Eisenmann E, Sparreboom A, Govindarajan R J Chromatogr B Analyt Technol Biomed Life Sci. 2024; 1242:124209.

PMID: 38905720 PMC: 11799840. DOI: 10.1016/j.jchromb.2024.124209.


Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice.

Li Y, Kazuki Y, Drabison T, Kobayashi K, Fujita K, Xu Y Drug Metab Dispos. 2023; 52(2):80-85.

PMID: 38071551 PMC: 10801630. DOI: 10.1124/dmd.123.001466.


Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method.

Talebi Z, Garrison D, Eisenmann E, Parmar K, Shapiro G, Rudek M Heliyon. 2023; 9(11):e20972.

PMID: 37908705 PMC: 10613910. DOI: 10.1016/j.heliyon.2023.e20972.


References
1.
Korfmacher W, Cox K, Ng K, Veals J, Hsieh Y, Wainhaus S . Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery. Rapid Commun Mass Spectrom. 2001; 15(5):335-40. DOI: 10.1002/rcm.235. View

2.
Liu B, Chang J, Gordon W, Isbell J, Zhou Y, Tuntland T . Snapshot PK: a rapid rodent in vivo preclinical screening approach. Drug Discov Today. 2008; 13(7-8):360-7. DOI: 10.1016/j.drudis.2007.10.014. View

3.
Reddy J, Madishetti S, Vachaspati P . Fast mouse PK (Fast PK): a rapid screening method to increase pharmacokinetic throughput in pre-clinical drug discovery. Eur J Pharm Sci. 2012; 47(2):444-50. DOI: 10.1016/j.ejps.2012.07.001. View

4.
Leblanc A, Sprowl J, Alberti P, Chiorazzi A, Arnold W, Gibson A . OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. J Clin Invest. 2018; 128(2):816-825. PMC: 5785270. DOI: 10.1172/JCI96160. View

5.
Berman J, Halm K, Adkison K, Shaffer J . Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput. J Med Chem. 1997; 40(6):827-9. DOI: 10.1021/jm960702s. View